PharmEasy plans $200 million fund raising at lower valuation: Report Posted on July 19, 2022 Drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion, two people with direct knowledge of deal talks told Reuters.
Leave a Reply